Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Statins for aortic stenosis? Still waiting for answers

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 358–359 (2007)Cite this article

boxed-textMoura LM et al. (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49: 554–561

Cardiac risk factor evaluation and treatment is appropriate in adults with calcific aortic stenosis, but there is still no convincing evidence that more aggressive lipid lowering therapy will prevent disease progression

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Freeman RV and Otto CM (2005) Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111: 3316–3326

    Article  Google Scholar 

  2. O'Brien KD (2006) Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26: 1721–1728

    Article  CAS  Google Scholar 

  3. Rosenhek R et al. (2004) Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110: 1291–1295

    Article  CAS  Google Scholar 

  4. Cowell SJ et al. for the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389–2397

    Article  CAS  Google Scholar 

  5. Newby DE et al. (2006) Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? Heart 92: 729–734

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Cardiology, University of Washington, Box 356422, HSB Room AA522, 1959 NE Pacific Street, Seattle, WA 98195, USA cmotto@u.washington.edu

Authors and Affiliations

  1. CM Otto is the J Ward Kennedy-Hamilton Endowed Professor of Cardiology at the University of Washington, Seattle, WA, USA.,

    Catherine M Otto

Authors
  1. Catherine M Otto
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Otto, C. Statins for aortic stenosis? Still waiting for answers. Nat Rev Cardiol 4, 358–359 (2007). https://doi.org/10.1038/ncpcardio0907

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpcardio0907

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing